Lunai Bioworks (LNAI) received a Nasdaq delisting determination after failing to meet the exchangeâs $2.5M minimum stockholdersâ equity requirement. – The company reported a stockholdersâ deficit of $9.02M as of June 30, 2026. – Trading in the companyâs common stock is…
pected to be suspended at the opening of business on October 30, 2026. – Lunai (LNAI)Â intends to file Form 25 with the SEC around November 2, with the delisting expected to become effective around November 12